pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
anzutresgene autoleucel
anzutresgene autoleucel [INN]
Endometrial Cancer
Immatics NV
0 catalysts
Phase 3
apabetalone
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Bromodomain and extra-terminal motif (BET)
Resverlogix Corp
0 catalysts
Phase 3
apazunersen sodium
Angelman Syndrome
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
← prev
page 155 of 231
next →
131
Pain89
Neurology1
pre_registration
apitegromab
Spinal Muscular Atrophy (SMA)
Growth/differentiation factor 8
$SRRKScholar Rock Holding Corp
0 catalysts
Preclinical
apomorphine
Parkinson's Disease
Alar Pharmaceuticals Inc
0 catalysts
Marketed
apomorphine hydrochloride
Apomorphine Hydrochloride (apomorphine hydrochloride)
Parkinson's Disease
TruPharma LLC
0 catalysts
Preclinical
apomorphine palmitate
Apomorphine palmitate
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Leukos Biotech SL
0 catalysts
Marketed
apraclonidine hydrochloride
Iopidine (apraclonidine hydrochloride)
Ocular Hypertension
$HROWHARROW, INC.
0 catalysts
Phase 3
apraglutide
apraglutide [INN]
Short Bowel Syndrome
$IRWDIRONWOOD PHARMACEUTICALS INC
0 catalysts
Marketed
aprocitentan
Tryvio (aprocitentan)
Hypertension
Idorsia Pharmaceuticals US Inc
0 catalysts
Marketed
aprotinin + fibrinogen (human) + thrombin (human)
Tisseel (aprotinin + fibrinogen (human) + thrombin (human))
Hemorrhage
Baxter Healthcare Corp
0 catalysts
Phase 2
arcotatug tavatecan
arcotatug tavatecan [INN]
Pancreatic Ductal Adenocarcinoma
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Preclinical
arevirumab-3
Lassa Fever (Lassa Hemorrhagic Fever)
Zalgen Labs LLC
0 catalysts
Marketed
arformoterol tartrate
Arformoterol Tartrate (arformoterol tartrate)
Chronic Bronchitis
The Ritedose Corp
0 catalysts
Marketed
argatroban
Argatroban (argatroban)
Thrombosis
Mylan Institutional Inc
0 catalysts
Marketed
arimoclomol citrate
Miplyffa (arimoclomol citrate)
Niemann-Pick Disease Type C
$ZVRAZEVRA THERAPEUTICS, INC.
0 catalysts
Marketed
aripiprazole lauroxil ER
Aristada (aripiprazole lauroxil)
Schizophrenia
Alkermes US Holdings Inc
0 catalysts
Phase 3
arlocabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Marketed
armodafinil
Armodafinil (armodafinil)
Obstructive Sleep Apnea
CorePharma LLC
0 catalysts
Marketed
ascorbic acid
Ascor (ascorbic acid [INN])
Bronchiolitis Obliterans
Renovion Inc
0 catalysts
Phase 2
ascrinvacumab
Metastatic Hepatocellular Carcinoma (HCC)
Activin receptor type-1-like
Kintor Pharmaceutical Ltd
0 catalysts
Phase 2
asengeprast
asengeprast [INN]
Systemic Sclerosis (Scleroderma)
Certa Therapeutics Pty Ltd
0 catalysts
Marketed
asfotase alfa
Strensiq (asfotase alfa)
Hypophosphatasia
Alexion Pharmaceuticals Inc
0 catalysts
Phase 2
aspacytarabine hydrochloride
Astarabine (aspacytarabine hydrochloride)
Refractory Acute Myeloid Leukemia
Ayala Pharmaceuticals Inc.
0 catalysts
Marketed
aspirin
Vazalore (aspirin [INN])
Pain
$ASBPAspire Biopharma Holdings, Inc.
0 catalysts
Marketed
aspirin + dipyridamole ER
Aspirin + Dipyridamole (aspirin + dipyridamole)
Ischemic Stroke
Barr Laboratories Inc
0 catalysts
Phase 3
astegolimab
Chronic Obstructive Pulmonary Disease (COPD)
IL-33 receptor (ST2)
F. Hoffmann-La Roche Ltd
0 catalysts
pre_registration
atacicept
IgA Nephropathy (Berger's Disease)
Tumor necrosis factor ligand superfamily member 13BTumor necrosis factor ligand superfamily member 13
$VERAVera Therapeutics, Inc.
0 catalysts
Phase 3
ataciguat
ataciguat [INN]
Aortic Valve Stenosis
Kardigan Inc
0 catalysts
Marketed
atazanavir sulfate
Atazanavir Sulfate (atazanavir sulfate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Laurus Labs Ltd
0 catalysts